Literature DB >> 28940788

A naturalistic longitudinal analysis of post-detoxification outcomes in opioid-dependent patients.

Jo-Hanna Ivers1, Lina Zgaga1, Brion Sweeney2, Eamon Keenan3,4, Catherine Darker1, Bobby P Smyth1,3, Joe Barry1,3.   

Abstract

INTRODUCTION AND AIMS: To provide an assessment of outcomes in a cohort of opioid-dependent patients post-detoxification. DESIGN AND METHODS: This study employed an observational longitudinal cohort design. Patients who completed detoxification in the three major Drug Dependency Units in Ireland during a 14-month period were included in the study (n = 143). Patients opting for one of the three pathways post-detoxification (inpatient aftercare, outpatient aftercare or no formal aftercare) were assessed in the final week of detoxification and followed up after 3, 6 and 9 months. The primary outcome was abstinence following detoxification.
RESULTS: A Cox (adjusted) model indicated participants who opted for outpatient aftercare treatment lapsed/relapsed at a rate of 52% higher than the inpatient aftercare group (hazard ratio = 1.52, 95% confidence interval 0.75-3.08, P = 0.24). Moreover, time to lapse/relapse was considerably shorter for the no formal aftercare group (hazard ratio = 7.68, 95% confidence interval 4.30-13.73, P = 5.75 × 10-12 ). Abstinence rates for outpatient aftercare and inpatient aftercare are about equal after 9 months. DISCUSSION AND
CONCLUSION: Patients who opt for aftercare post-detoxification have significantly better outcomes at follow up when compared to no formal aftercare. In addition, patients' intention to attend aftercare affected their outcomes regardless of eventual treatment path.
© 2017 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  addiction; aftercare; detoxification; longitudinal; opioid dependent

Mesh:

Substances:

Year:  2017        PMID: 28940788     DOI: 10.1111/dar.12597

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  4 in total

1.  Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.

Authors:  Christine Timko; Maureen Below; Lisa Vittorio; Emmeline Taylor; Grace Chang; Steven Lash; Fe Erlita D Festin; Deborah Brief
Journal:  J Subst Abuse Treat       Date:  2019-01-04

2.  Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.

Authors:  Kelly E Dunn; Elise M Weerts; Andrew S Huhn; Jennifer R Schroeder; David Andrew Tompkins; George E Bigelow; Eric C Strain
Journal:  Addict Biol       Date:  2018-10-08       Impact factor: 4.280

3.  Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management.

Authors:  Jumi Hayaki; Micah T Conti; Genie L Bailey; Debra S Herman; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2021-01-27

4.  Tracking Study on the Relapse and Aftercare Effect of Drug Patients Released From a Compulsory Isolated Detoxification Center.

Authors:  Nian Liu; Zekai Lu; Ying Xie
Journal:  Front Psychiatry       Date:  2022-01-17       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.